Clinical Trial Update: PurTox (Botulinum Toxin Type A) for the Treatment of Adult Onset Spasmodic Torticollis/Cervical Dystonia [Phase 1]

View source ↗

Summary

Phase 1 study of PurTox, a botulinum toxin type A formulation, for adult-onset spasmodic torticollis (cervical dystonia) has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Dystonia

Drugs mentioned

• PurTox

Snippet

Sponsor: Mentor Worldwide, LLC | Conditions: Spasmodic Torticollis | Phase 1 | Status: COMPLETED